Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hopwood

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of lifeM A Richards, P Hopwood, A J Ramirez, et al.
Lancet (London, England)|June 6, 2002
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field studyM A Sprangers, M Groenvold, J I Arraras, et al.
British Journal of Cancer|August 13, 2009
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stageS J Howell, C Searle, V Goode, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Community Genetics|August 28, 2004
Cancer genetics service provision: a comparison of seven European centresP Hopwood, C J van Asperen, G Borreani, et al.
Journal of Medical Genetics|November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centresD G R Evans, A D Baildam, E Anderson, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of lifeM A Richards, P Hopwood, A J Ramirez, et al.
Lancet (London, England)|June 6, 2002
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field studyM A Sprangers, M Groenvold, J I Arraras, et al.
British Journal of Cancer|August 13, 2009
The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stageS J Howell, C Searle, V Goode, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesH E Campbell, D Epstein, D Bloomfield, et al.
Community Genetics|August 28, 2004
Cancer genetics service provision: a comparison of seven European centresP Hopwood, C J van Asperen, G Borreani, et al.
Journal of Medical Genetics|November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centresD G R Evans, A D Baildam, E Anderson, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Pageof 7